skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Journals@Ovid Complete remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
1,25-Dihydroxyvitamin D 3 induces biphasic NF-κB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IκB
1,25-Dihydroxyvitamin D 3 induces biphasic NF-κB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IκB
Material Type:
Artigo 		Adicionar ao Meu Espaço

1,25-Dihydroxyvitamin D 3 induces biphasic NF-κB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IκB

Tse, Anfernee Kai-Wing ; Wan, Chi-Keung ; Shen, Xiao-Ling ; Zhu, Guo-Yuan ; Cheung, Hon-Yeung ; Yang, Mengsu ; Fong, Wang-Fun

Experimental cell research, 2007-05, Vol.313 (8), p.1722-1734 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO
5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO
Material Type:
Artigo 		Adicionar ao Meu Espaço

5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO

Hayakawa, Jun ; Joyal, Elizabeth G. ; Gildner, Jean F. ; Washington, Kareem N. ; Phang, Oswald A. ; Uchida, Naoya ; Hsieh, Matthew M. ; Tisdale, John F.

Transfusion (Philadelphia, Pa.), 2010-10, Vol.50 (10), p.2158-2166 [Periódico revisado por pares]

Malden, USA: Blackwell Publishing Inc

Texto completo disponível

Citações Citado por
3
947OCOMPARISON OF EFFICACY AND SAFETY OF 5-DAY AND 10-DAY SCHEDULES OF SGI-110, A NOVEL SUBCUTANEOUS (SC) HYPOMETHYLATING AGENT (HMA), IN THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)
947OCOMPARISON OF EFFICACY AND SAFETY OF 5-DAY AND 10-DAY SCHEDULES OF SGI-110, A NOVEL SUBCUTANEOUS (SC) HYPOMETHYLATING AGENT (HMA), IN THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)
Material Type:
Artigo 		Adicionar ao Meu Espaço

947OCOMPARISON OF EFFICACY AND SAFETY OF 5-DAY AND 10-DAY SCHEDULES OF SGI-110, A NOVEL SUBCUTANEOUS (SC) HYPOMETHYLATING AGENT (HMA), IN THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)

Roboz, G.J ; Ravandi, F ; Kropf, P ; Yee, K ; O'Connell, C ; Griffiths, E ; Stock, W ; Garcia-Manero, G ; Jabbour, E ; Daver, N ; Pemmaraju, N ; Issa, J ; Walsh, K ; Rizzieri, D ; Lunin, S ; Naim, S ; Hao, Y ; Azab, M ; Kantarjian, H

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv328-iv328 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
4
AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia
AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

Cooper, Todd M. ; Alonzo, Todd A. ; Gerbing, Robert B. ; Perentesis, John P. ; Whitlock, James A. ; Taub, Jeffrey W. ; Horton, Terzah M. ; Gamis, Alan S. ; Meshinchi, Soheil ; Loken, Michael R. ; Razzouk, Bassem I.

Cancer, 2014-08, Vol.120 (16), p.2482-2489 [Periódico revisado por pares]

Hoboken, NJ: Wiley-Blackwell

Texto completo disponível

Citações Citado por
5
Aberrant cytokine signaling in leukemia
Aberrant cytokine signaling in leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aberrant cytokine signaling in leukemia

Van Etten, R A

Oncogene, 2007-10, Vol.26 (47), p.6738-6749 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells

Pardanani, A ; Lasho, T ; Chen, D ; Kimlinger, T K ; Finke, C ; Zblewski, D ; Patnaik, M M ; Reichard, K K ; Rowinsky, E ; Hanson, C A ; Brooks, C ; Tefferi, A

Leukemia, 2015-07, Vol.29 (7), p.1605-1608 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer
Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer

Ugolkov, Andrey V ; Matsangou, Maria ; Taxter, Timothy J ; O'Halloran, Thomas V ; Cryns, Vincent L ; Giles, Francis J ; Mazar, Andrew P

Oncology letters, 2018-11, Vol.16 (5), p.6437-6444

Greece: Spandidos Publications UK Ltd

Texto completo disponível

Citações Citado por
8
Aberrantly activated anti‐apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets
Aberrantly activated anti‐apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aberrantly activated anti‐apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets

Gitendra Wickremasinghe, R. ; Prentice, Archibald G. ; Steele, Andrew J.

British journal of haematology, 2011-06, Vol.153 (5), p.545-556 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
9
ABO, alemtuzumab and allogeneic transplantation
ABO, alemtuzumab and allogeneic transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

ABO, alemtuzumab and allogeneic transplantation

Cooling, L

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.881-883 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
Material Type:
Artigo 		Adicionar ao Meu Espaço

ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue

Cooling, L

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.881 [Periódico revisado por pares]

Nature Publishing Group

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1.343)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.394)
  2. Reports  (6)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1996  (11)
  2. 1996Até2002  (91)
  3. 2003Até2009  (360)
  4. 2010Até2017  (601)
  5. Após 2017  (338)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (183)
  2. Alemão  (2)
  3. Norueguês  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.